## **Core Concept**
Tumor lysis syndrome (TLS) is a life-threatening complication that occurs when a large number of cancer cells die rapidly, releasing their contents into the bloodstream. This leads to several metabolic abnormalities, including hyperuricemia, hyperphosphatemia, hypocalcemia, and hyperkalemia.

## **Why the Correct Answer is Right**
The correct answer, , is associated with tumor lysis syndrome because TLS leads to the release of intracellular contents from lysed cancer cells. Uric acid, phosphate, and potassium levels increase, while calcium levels decrease due to the formation of calcium phosphate crystals.

## **Why Each Wrong Option is Incorrect**
* **Option A:** Hyperuricemia is a hallmark of TLS due to the breakdown of nucleic acids from cancer cells into uric acid.
* **Option B:** Hyperphosphatemia occurs because cancer cells contain high levels of phosphate, which is released into the bloodstream upon cell lysis.
* **Option D:** Hyperkalemia is seen in TLS as a result of the release of potassium from lysed cancer cells.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that TLS is most commonly associated with cancers that have a high cell turnover rate, such as acute lymphoblastic leukemia (ALL) and Burkitt lymphoma. Early recognition and aggressive management of TLS are crucial to prevent serious complications.

## **Correct Answer:** . Hypocalcemia